D. E. Shaw & Co., Inc. Abiomed Inc Call Options Transaction History

D. E. Shaw & Co., Inc.

$107 Billion
Q3 2024

Call Options

19 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Aug 15, 2022	SELL	$224.73 - $338.64 $2.72 Million - $4.1 Million	-12,100 Reduced 91.67%	1,100 $272,000
Q1 2022 May 16, 2022	SELL	$277.25 - $366.29 $8.26 Million - $10.9 Million	-29,800 Reduced 69.3%	13,200 $4.37 Million
Q4 2021 Feb 14, 2022	BUY	$300.63 - $371.35 $1.2 Million - $1.49 Million	4,000 Added 10.26%	43,000 $15.4 Million
Q3 2021 Nov 15, 2021	BUY	$310.19 - $376.2 $3.1 Million - $3.76 Million	10,000 Added 34.48%	39,000 $12.7 Million
Q2 2021 Aug 16, 2021	SELL	$262.71 - $351.17 $2.94 Million - $3.93 Million	-11,200 Reduced 27.86%	29,000 $9.05 Million
Q1 2021 May 17, 2021	SELL	$285.92 - $355.13 $1.29 Million - $1.6 Million	-4,500 Reduced 10.07%	40,200 $12.8 Million
Q4 2020 Feb 16, 2021	SELL	$251.88 - $324.2 $3.78 Million - $4.86 Million	-15,000 Reduced 25.13%	44,700 $14.5 Million
Q3 2020 Nov 16, 2020	BUY	$255.22 - $317.0 $7.84 Million - $9.73 Million	30,700 Added 105.86%	59,700 $16.5 Million
Q2 2020 Aug 14, 2020	BUY	$141.4 - $257.09 $2.86 Million - $5.19 Million	20,200 Added 229.55%	29,000 $7.01 Million
Q1 2020 May 15, 2020	SELL	$130.51 - $196.01 $1.47 Million - $2.21 Million	-11,300 Reduced 56.22%	8,800 $1.28 Million
Q4 2019 Feb 14, 2020	BUY	$159.31 - $223.54 $446,068 - $625,912	2,800 Added 16.18%	20,100 $3.43 Million
Q3 2019 Nov 14, 2019	SELL	$175.89 - $279.23 $193,478 - $307,153	-1,100 Reduced 5.98%	17,300 $3.08 Million
Q2 2019 Aug 14, 2019	SELL	$250.96 - $284.94 $6.32 Million - $7.18 Million	-25,200 Reduced 57.8%	18,400 $4.79 Million
Q1 2019 May 15, 2019	SELL	$276.39 - $362.25 $5.03 Million - $6.59 Million	-18,200 Reduced 29.45%	43,600 $12.5 Million
Q4 2018 Feb 14, 2019	BUY	$281.08 - $444.25 $4.98 Million - $7.86 Million	17,700 Added 40.14%	61,800 $20.1 Million
Q3 2018 Nov 14, 2018	BUY	$354.53 - $449.75 $425,435 - $539,700	1,200 Added 2.8%	44,100 $19.8 Million
Q2 2018 Aug 14, 2018	BUY	$278.07 - $446.21 $166,842 - $267,726	600 Added 1.42%	42,900 $17.5 Million
Q1 2018 May 15, 2018	BUY	$192.49 - $295.85 $3.85 Million - $5.92 Million	20,000 Added 89.69%	42,300 $12.3 Million
Q4 2017 Feb 14, 2018	BUY	$168.78 - $199.74 $3.76 Million - $4.45 Million	22,300	22,300 $4.18 Million

Others Institutions Holding ABMD

# of Institutions

Shares Held

137K

Call Options Held

Put Options Held

View Full List

About ABIOMED INC

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

More about ABMD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account